ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · IEX Real-Time Price · USD
9.21
+0.15 (1.66%)
May 17, 2024, 4:00 PM EDT - Market closed

ADMA Biologics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018 - 2011
Net Income
-28.24-65.9-71.65-75.75-48.28
Upgrade
Depreciation & Amortization
8.337.115.53.943.26
Upgrade
Share-Based Compensation
6.195.223.492.862.65
Upgrade
Other Operating Activities
22.52-5.93-49.71-33.05-33.82
Upgrade
Operating Cash Flow
8.8-59.51-112.37-102-76.19
Upgrade
Capital Expenditures
-4.77-13.91-13.51-12.72-3.81
Upgrade
Other Investing Activities
-0.21----
Upgrade
Investing Cash Flow
-4.98-13.91-13.51-12.72-3.81
Upgrade
Share Issuance / Repurchase
1.164.82121.14131.2148.47
Upgrade
Debt Issued / Paid
-25.1951.71-0.0313.5238.03
Upgrade
Other Financing Activities
-14.91-7.68-0.06-0.83-6.5
Upgrade
Financing Cash Flow
-38.99108.85121.05143.980
Upgrade
Net Cash Flow
-35.1735.43-4.8329.17-0
Upgrade
Free Cash Flow
4.03-73.42-125.88-114.73-80.01
Upgrade
Free Cash Flow Margin
1.56%-47.65%-155.52%-271.74%-272.60%
Upgrade
Free Cash Flow Per Share
0.02-0.37-0.90-1.33-1.47
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).